The Alfred E. Mann Foundation for Scientific Research (AMF) today confirmed the appointment of two new senior executives.
Los Angeles-based AMF appointed Charles Nelson as its new COO and Corey Dishmon as its chief legal officer/chief business officer.
Nelson joins AMF from Alcon, where he oversaw the manufacturing science and technology organization. He is a veteran of 38 years in the medical device industry, having also worked as CTO/COO of Sonoma Orthopedic Products, a company he founded that was acquired by Arthrex, according to a news release.
“AMF has a long history of incubating and developing breakthrough technologies, and I’m excited to help drive the company further along its path,” Nelson said in the release. “I look forward to contributing to the team and their mission to improve lives through medical technology.”
Dishmon previously served as Global General Counsel and Head of Business Development and Corporate Secretary at Siemens Healthineers’ Molecular Diagnostics business. She has more than 20 years of experience in healthcare and medical devices, AMF said, with previous years spent at Monogram Biosciences.
“I’m thrilled to join such an innovative, dynamic organization,” Dishmon said. “AMF is advancing its mission to develop cutting-edge medical devices to improve lives, and I look forward to the opportunity to contribute to its continued growth.”
Both appointments complete AMF’s executive leadership team, the company said, and go into effect immediately.
“Charles’ proven experience in the medical technology industry and legacy of strategic and operational leadership accomplishments will no doubt contribute to our future success,” AMF Chairman & CEO Dr. Robert J. Greenberg said. “Corey’s expertise in complex commercial transactions, strategic business development, IP, regulatory and compliance matters will also help us advance our long-term goals.
“With these key positions in place, AMF is well poised to continue to fulfill its mission of providing innovative solutions for medical conditions with high unmet needs.”
